An essential amino acid for human development; precursor of serotonin, q.v. Isoln from casein: F. G. Hopkins, S. W. Cole, J. Physiol. 27, 418 (1902). Structure: A. Ellinger, Ber. 39, 2515 (1906); A. Ellinger, A. C. Flamand, Ber. 40, 3029 (1907). Early chemistry and biochemistry: Amino Acids and Proteins, D. M. Greenberg, Ed. (Charles C. Thomas, Springfield, IL, 1951) 950 pp., passim; J. P. Greenstein, M. Winitz, Chemistry of the Amino Acids vols 1-3 (John Wiley and Sons, Inc., New York, 1961) pp. 2316-2347, passim. Intrinsic fluorescent/phosphorescent moiety in proteins; used in characterizing structure and conformational changes: E. A. Burstein et al., Photochem. Photobiol. 18, 263 (1973); C. Pokalsky et al., J. Biol. Chem. 270, 3809 (1995); review of phosphorescence: S. Papp, J. M. Vanderkooi, Photochem. Photobiol. 49, 775-784 (1989). Review of microbial production: T. K. Maiti, S. P. Chatterjee, Hind. Antibiot. Bull. 33, 26-61 (1991). Review of biosynthesis: I. P. Crawford, G. V. Stauffer, Annu. Rev. Biochem. 49, 163-195 (1980); of nutrition and metabolism: J. C. Peters. Adv. Exp. Med. Biol. 294, 345-358 (1991). Review of use in depression: S. N. Young, J. Psychiatry Neurosci. 16, 241-246 (1991); in neuropsychiatric disorders: R. Sandyk, Int. J. Neurosci. 67, 127-144 (1992). Review as toxic agent in eosinophilia-myalgia syndrome (EMS): D. S. Milburn, C. W. Myers, DICP Ann. Pharmacother. 25, 1259 (1991); L. D. Kaufman, R. M. Philen, Drug Saf. 8, 89-98 (1993).
In treatment of depression, schizophrenia and other neuropsychiatric disorders.
Antidepressant